| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.18B | +8.0% |
| Cost of Revenue | $244.6M | +7.3% |
| Gross Profit | $932.6M | +8.2% |
| R&D Expense | $294.5M | +11.2% |
| SG&A Expense | $150.9M | +9.8% |
| Operating Income | $83.2M | +4.5% |
| Interest Expense | $10.7M | +76.1% |
| Pre-tax Income | $98.7M | +15.9% |
| Income Tax | -$16.7M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $375.1M | -39.9% |
| Short-term Investments | $102.9M | +4.8% |
| Accounts Receivable | $325.1M | +11.1% |
| Current Assets | $891.3M | -18.8% |
| Total Assets | $1.55B | -7.3% |
| Current Liabilities | $802.7M | -13.0% |
| Long-term Debt | $451.0M | +0.5% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $356.4M | +7.3% |
| Capital Expenditures | $6.1M | +136.1% |
| Investing Cash Flow | -$42.7M | -84.0% |
| Financing Cash Flow | -$569.5M | -813.3% |
| Free Cash Flow | $350.4M | +6.3% |
| +89.6% |
| Net Income | $115.4M | -52.8% |
| EPS (Basic) | $0.60 | -57.1% |
| EPS (Diluted) | $0.58 | -57.4% |
| Total Liabilities |
| $1.35B |
| -8.2% |
| Stockholders' Equity | -$299.3M | -0.8% |